Increasing number of stroke specialists should contribute to utilization of IV rt-PA: Results of questionnaires from 1466 hospitals in Japan

Journal of the Neurological Sciences

Volumn 279, Issue 1-2, 2009, Pages 66-69

  Iguchi, Yasuyuki ^a,b   Kimura, Kazumi ^a,b   Shibazaki, Kensaku ^a,b   Iwanaga, Takeshi ^a,b  

^a Japan Transportation and Early Admission Management for Acute Stroke Patients ^*  (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

rt PA; Stroke center; Stroke physician; Thrombolysis

Indexed keywords

ALTEPLASE;

ARTICLE; CONTROLLED STUDY; DRUG USE; HOSPITAL; JAPAN; MEDICAL SPECIALIST; PRIORITY JOURNAL; QUESTIONNAIRE; STROKE;

CONFIDENCE INTERVALS; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; INFUSIONS, INTRAVENOUS; JAPAN; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; NEUROLOGY; ODDS RATIO; QUESTIONNAIRES; RECOMBINANT PROTEINS; SPECIALISM; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 60949108178     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.016     Document Type: Article

References (15)

1. Kimura K., Minematsu K., Kazui S., and Yamaguchi T. Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis. 19 (2005) 171-178
2. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 (1995) 1581-1587
3. Yamaguchi T., Mori E., Minematsu K., et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37 (2006) 1810-1815
4. Kleindorfer D., Lindsell C.J., Brass L., Koroshetz W., and Broderick J.P. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39 (2008) 924-928
5. Kimura K., Kazui S., Minematsu K., and Yamaguchi T. Analysis of 16,922 patients with acute ischemic stroke and transient ischemic attack in Japan. A hospital-based prospective registration study. Cerebrovasc Dis. 18 (2004) 47-56
6. Alberts M.J., Latchaw R.E., Selman W.R., et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 36 (2005) 1597-1616
7. Leira E.C., Lamb D.L., Nugent A.S., et al. Feasibility of acute clinical trials during aerial interhospital transfer. Stroke. 37 (2006) 2504-2507
8. Schwab S., Vatankhah B., Kukla C., et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology. 69 (2007) 898-903
9. Cadilhac D.A., Ibrahim J., Pearce D.C., et al. Multicenter comparison of processes of care between Stroke Units and conventional care wards in Australia. Stroke 35 (2004) 1035-1040
10. Alberts M.J., Hademenos G., Latchaw R.E., et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. Jama 283 (2000) 3102-3109
11. Launois R., Giroud M., Megnigbeto A.C., et al. Estimating the cost-effectiveness of stroke units in France compared with conventional care. Stroke. 35 (2004) 770-775
12. Culebras A., Kase C.S., Masdeu J.C., et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association. Stroke 28 (1997) 1480-1497
13. Barber P.A., Darby D.G., Desmond P.M., et al. Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography. Stroke 30 (1999) 2059-2065
14. Kimura K., Iguchi Y., Yamashita S., Shibazaki K., Kobayashi K., and Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J Neurol Sci. 267 (2008) 57-61
15. Kimura K., Iguchi Y., Shibazaki K., et al. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. J Neurol Sci (2008)